World markets gained broadly amidst upbeat economic data and waning concerns over the tight monetary policy outlook. China’s stimulus measures also helped the rally at the bourses. However, caution remains over what would emerge from the Jackson Hole Symposium of the Fed.
Asian stocks rallied. European stocks are trading mostly higher. Wall Street Futures are also in mildly positive territory.
Safe haven Dollar weakened and the Dollar Index declined. Bond yields eased across regions. Crude oil prices continued to rise on supply concerns. Gold rallied amidst a weakening Dollar. Cryptocurrencies continued to gain.
Here is a snapshot of the world markets at this hour across stocks, currencies, bonds, commodities and cryptocurrencies.
Stock Indexes:
DJIA (US30) at 33,058.10, up 0.27%
S&P 500 (US500) at 4,159.40, up 0.45%
Germany’s DAX at 13,226.71, up 0.05%
U.K.’s FTSE 100 at 7,491.30, up 0.26%
France’s CAC 40 at 6,386.43, down 0.01%
Euro Stoxx 50 at 3,667.95, up 0.01%
Japan’s Nikkei 225 at 28,479.01, up 0.58%
Australia’s S&P ASX 200 at 7,048.10, up 0.71%
China’s Shanghai Composite at 3,246.25, up 0.97%
Hong Kong’s Hang Seng at 19,968.38, up 3.63%
Currencies:
EURUSD at 0.9996, up 0.31%
GBPUSD at 1.1844, up 0.39%
USDJPY at 136.44, down 0.49%
AUDUSD at 0.6983, up 1.11%
USDCAD at 1.2907, down 0.45%
Dollar Index at 108.21, down 0.43%
Ten-Year Govt Bond Yields:
U.S. at 3.087%, down 0.61%
Germany at 1.3390%, down 1.47%
France at 1.947%, down 1.12%
U.K. at 2.6570%, down 1.48%
Japan at 0.224%, down 2.61%
Commodities:
Crude Oil WTI Futures (Sep) at $95.31, up 0.44%
Brent Oil Futures (Oct) at $101.87, up 0.64%
Gold Futures (Dec) at $1,776.25, up 0.84%
Cryptocurrencies:
Bitcoin at $21,734.18, up 1.65%
Ethereum at $1,706.29, up 4.18%
BNB at $303.88, up 2.61%
XRP at $0.3481, up 1.56%
Cardano at $0.4665, up 1.70%
Source: Read Full Article
-
$BTC: IIF’s Chief Economist Calls Bitcoin “Just Another Bubble Asset”
-
$BTC: Popular Crypto Analyst Points to Bullish Pattern Suggesting Bitcoin Could Trade at $80,000 Next Year
-
Bitcoin ($BTC) Price to Rise to $30,000 in Second Half of 2023, VanEck Says
-
Bellerophon Therapeutics Surges 30% On Share Subscription Agreement With An Institutional Investor
-
Axonics Increases 11% As Q4 Prel. Revenue Better Than View